Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine

MC Ritz and MJ Kuhar

Neuroscience Branch, National Institute on Drug Abuse Addiction Research Center, Baltimore, Maryland.

Amphetamine and cocaine, commonly abused psychostimulants, often produce similar physiologic and behavioral effects in both animals and humans. We have shown previously that the reinforcing effects of cocaine can be correlated with drug binding to the mazindol and GBR 12935 binding sites on the dopamine transporter. In an attempt to identify the receptors associated with the reinforcing properties of amphetamine and related phenylethylamines, we have compared the potencies of these compounds in studies of drug reinforced behavior with their binding potencies at monoaminergic uptake sites and neurotransmitter receptor sites. The results of these experiments indicate that d-amphetamine exhibits a pharmacologically relevant micromolar affinity for dopamine, norepinephrine and serotonin uptake sites as well as for alpha-2 adrenergic receptor sites. Analysis of the data indicates that the reinforcing effects of phenylethylamines were not positively correlated with inhibition of ligand binding to any of the monoamine sites tested. However, the self-administration of amphetamine and related compounds may be inversely related to the inhibition of [3H]paroxetine binding to the serotonin transporter, suggesting that serotonin uptake inhibition opposes the reinforcing effects of amphetamine. This effect is not related to direct effects of drug binding at 5-HT2 receptor sites. Finally, amphetamine binding to alpha-2 adrenergic receptors suggests that these receptors could play a role in mediating the releasing or uptake inhibiting properties of the drug, and perhaps a role in some of its psychotomimetic effects.

Volume 248, Issue 3, pp. 1010-1017, 03/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. M. Rank, X. Li, D. J. Bennett, and M. A. Gorassini Role of Endogenous Release of Norepinephrine in Muscle Spasms After Chronic Spinal Cord Injury J Neurophysiol, May 1, 2007; 97(5): 3166 - 3180. [Abstract] [Full Text] [PDF]

				L. L. Howell, F. I. Carroll, J. R. Votaw, M. M. Goodman, and H. L. Kimmel Effects of Combined Dopamine and Serotonin Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 757 - 765. [Abstract] [Full Text] [PDF]

				S. Wee, K. G. Anderson, M. H. Baumann, R. B. Rothman, B. E. Blough, and W. L. Woolverton Relationship between the Serotonergic Activity and Reinforcing Effects of a Series of Amphetamine Analogs J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 848 - 854. [Abstract] [Full Text] [PDF]

				E. A. Budygin, M. S. Brodie, T. D. Sotnikova, Y. Mateo, C. E. John, M. Cyr, R. R. Gainetdinov, and S. R. Jones Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine PNAS, May 18, 2004; 101(20): 7781 - 7786. [Abstract] [Full Text] [PDF]

				J. A. Lile, Z. Wang, W. L. Woolverton, J. E. France, T. C. Gregg, H. M. L. Davies, and M. A. Nader The Reinforcing Efficacy of Psychostimulants in Rhesus Monkeys: The Role of Pharmacokinetics and Pharmacodynamics J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 356 - 366. [Abstract] [Full Text] [PDF]

				S. D. Mague, A. M. Pliakas, M. S. Todtenkopf, H. C. Tomasiewicz, Y. Zhang, W. C. Stevens Jr., R. M. Jones, P. S. Portoghese, and W. A. Carlezon Jr. Antidepressant-Like Effects of kappa -Opioid Receptor Antagonists in the Forced Swim Test in Rats J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 323 - 330. [Abstract] [Full Text]

				S. L. Sell and C. P. France Cocaine and Amphetamine Attenuate the Discriminative Stimulus Effects of Naltrexone in Opioid-Dependent Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1103 - 1110. [Abstract] [Full Text] [PDF]

				W.-X. Shi, C.-L. Pun, X.-X. Zhang, M. D. Jones, and B. S. Bunney Dual Effects of D-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors J. Neurosci., May 1, 2000; 20(9): 3504 - 3511. [Abstract] [Full Text] [PDF]

				S. Jones and J. A. Kauer Amphetamine Depresses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area J. Neurosci., November 15, 1999; 19(22): 9780 - 9787. [Abstract] [Full Text] [PDF]

				M. A. Nader, K. A. Grant, H. M. L. Davies, R. H. Mach, and S. R. Childers The Reinforcing and Discriminative Stimulus Effects of the Novel Cocaine Analog 2beta -Propanoyl-3beta -(4-Tolyl)-Tropane in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 541 - 550. [Abstract] [Full Text]

				B. Hoffman, E Mezey, and M. Brownstein Cloning of a serotonin transporter affected by antidepressants Science, October 25, 1991; 254(5031): 579 - 580. [Abstract] [PDF]